[1] Haverkamp W, Breithardt G, Camm AJ, et al.The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a policy conference of the European Society of Cardiology[J]. Eur Heart J, 2000, 21(15):1216-1231.
[2] Hondeghem L, Carlsson L, Duker G.Instability and triangulation of the action potential predict serious proarrhythmia, but action potential duration prolongation is antiarrhythmic[J]. Circulation, 2001, 103(15):2004-2013.
[3] Malik M, Farbom P, Batchvarov V, et al.Relation between QT and RR intervals is highly individual among healthy subjects: Implications for heart rate correction of the QT interval[J]. Heart, 2002, 87(3):220-228.
[4] Schnell CR, Wood JM.Measurement of blood pressure and heart rate by telemetry in conscious unrestrained marmosets[J]. Am J Physiol, 1993, 264(5):1509-1516.
[5] Honda M, Komatsu R, Isobe T, et al.Involvement of the autonomic nervous system in diurnal variation of corrected QT intervals in common marmosets[J]. J Pharmacol Sci,2013, 121(2):131-137.
[6] Tabo M, Hara T, Sone S, et al.Prediction of drug-induced QT interval prolongation in telemetered common marmosets[J]. J Toxicol Sci, 2008, 33(3):315-325.
[7] Honda M, Komatsu R, Holzgrefe HH, et al.Application of probabilistic analysis for precisely correcting the QT interval for heart in telemetered common marmosets[J]. J Pharmacol Toxicol Methods, 2010, 61(3):264-270.
[8] Horri I, Kito G, Hamada T, et al.Development of telemetry system in the common marmoset-cardiovascular effects of astemizole and nicardipine[J]. J Toxicol Sci, 2001, 27(2):123-130.
[9] Schnell CR, Wood JM.Measurement of blood pressure and heart rate by telemetry in conscious unrestrained marmosets[J]. Lab Anim, 1995, 29(3):258-261.
[10] Hoffmann K, Coolen A, Schlumbohm C, et al.Remote long-term registrations of sleep-wake rhythms, core body temperature and activity in marmoset monkeys[J]. Behav Brain Res, 2012, 235(2):113-123.
[11] Holzgrefe H, Ferber G, Champeroux P, et al.Preclinical QT safety assessment: cross-species comparisons and human translation from an industry consortium[J]. J Pharmacol Toxicol Methods, 2014, 69(1):61-101.
(下转第509页) |
